| For: | Maccaroni E, Giampieri R, Lenci E, Scortichini L, Bianchi F, Belvederesi L, Brugiati C, Pagliaretta S, Ambrosini E, Berardi R. BRCA mutations and gastrointestinal cancers: When to expect the unexpected? World J Clin Oncol 2021; 12(7): 565-580 [PMID: 34367929 DOI: 10.5306/wjco.v12.i7.565] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i7/565.htm |
| Number | Citing Articles |
| 1 |
Gulnur Zhunussova, Nazgul Omarbayeva, Dilyara Kaidarova, Saltanat Abdikerim, Natalya Mit, Ilya Kisselev, Kanagat Yergali, Aigul Zhunussova, Tatyana Goncharova, Aliya Abdrakhmanova, Leyla Djansugurova. Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity. Oncotarget 2023; 14(1) doi: 10.18632/oncotarget.28518
|
| 2 |
Evgeny N Imyanitov, Ekaterina S Kuligina, Anna P Sokolenko, Evgeny N Suspitsin, Grigoriy A Yanus, Aglaya G Iyevleva, Alexandr O Ivantsov, Svetlana N Aleksakhina. Hereditary cancer syndromes. World Journal of Clinical Oncology 2023; 14(2): 40-68 doi: 10.5306/wjco.v14.i2.40
|
| 3 |
Gyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, Attila Marcell Szasz, Zoltan Herold, Magdolna Dank. Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors. Biomedicines 2024; 12(3) doi: 10.3390/biomedicines12030593
|
| 4 |
Naman Batra, Saurabh Mittal, Sushama Talegaonkar. Drug Targeting Complexity. 2026; doi: 10.1016/B978-0-443-43846-2.00007-6
|
| 5 |
Yi‐Ru Bai, Wei‐Guang Yang, Rui Jia, Ju‐Shan Sun, Dan‐Dan Shen, Hong‐Min Liu, Shuo Yuan. The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer. Medicinal Research Reviews 2025; 45(1) doi: 10.1002/med.22069
|
| 6 |
Swaroop Kumar Pandey, Swarnima Paliwal, Braj Bhushan Mall. BRCA1 Mutations and Their Consequences in Multiple Cancers: Molecular Insights and Emerging Therapeutic Strategies. Current Cancer Therapy Reviews 2026; 22(5) doi: 10.2174/0115733947394022250929081154
|
| 7 |
Fatemeh Ghorbani Parsa, Stefania Nobili, Mina Karimpour, Hamid Asadzadeh Aghdaei, Ehsan Nazemalhosseini-Mojarad, Enrico Mini. Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy. Journal of Personalized Medicine 2022; 12(3) doi: 10.3390/jpm12030396
|
| 8 |
Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.881100
|
| 9 |
T. V. Schäfer, O. A. Vakunenkova, K. V. Firsov, Ju. Ju. Ivnitsky. Self-Destructive Behavior among Predictors of Cancer Incidence. Biology Bulletin Reviews 2022; 12(6) doi: 10.1134/S2079086422060081
|
| 10 |
Marwa Mohammed Ali Jassim, Shaymaa A. Naji, Majid Mohammed Mahmood. BRCA1, BCL2, and the RB Tumor Suppressor have abnormal expressions in lung cancer. Research Journal of Pharmacy and Technology 2022; doi: 10.52711/0974-360X.2022.00685
|
| 11 |
N. S. Prizova, L. V. Bolotina, A. L. Kornietskaya, S. F. Evdokimova. BRCA mutation as a predictor of systemic therapy response in a patient with synchronous multiple primary cancer (breast, ovarian, and gastric cancer). Meditsinskiy sovet = Medical Council 2026; (21) doi: 10.21518/ms2025-515
|
| 12 |
Katie Meehan, Leanne Pilkington, Azim Khan, Nicholas Pachter, Lisa Spalding, Ayeisha Milligan Armstrong, Cameron Redfern, Andrew Redfern. Exploring Traditional Breast Cancer Risk Genes Among Aboriginal and Torres Strait Islander Women. Life 2026; 16(8) doi: 10.3390/life16081375
|
| 13 |
Kaler Amrit Kaur, Upadhyay Shraddha Manoj , Bora Nandini Shyamali , Nikam Ankita , P Kavya , Athikeri Nivetha , Solanki Dattatray B , Shaikh Imran , Mistry Rajesh . Germline BRCA1 Mutation inSquamous Cell Carcinoma of Oesophagus: Driver versus Passenger Mutation. Journal of Genetic Medicine and Gene Therapy 2024; 7(1) doi: 10.29328/journal.jgmgt.1001011
|
| 14 |
Francisco Cezar Aquino de Moraes, Gustavo Tadeu Freitas Uchôa Matheus, Maria Eduarda Cavalcanti Souza, Rommel Mario Rodriguez Burbano. Gastric cancer risk and BRCA1/2 mutations: a systematic review and meta-analysis. Personalized Medicine 2025; 22(4) doi: 10.1080/17410541.2025.2531737
|
| 15 |
Sabastain F Forsah, Sini Bijoy, Divine Besong Arrey Agbor, Derek Ugwendum, Margarieta Okang, Uroosa M Syed, Cinthya Aviles, Jay Nfonoyim. Metastatic Early-Onset Colon Cancer With BRCA2 Mutation Presenting With a Large Obstructing Pelvic Mass and Causing Acute Liver Failure and Acute Hypoxic Respiratory Failure. Cureus 2024; doi: 10.7759/cureus.64770
|
| 16 |
Airat Bilyalov, Sergey Nikolaev, Anastasiia Danishevich, Igor Khatkov, Komron Makhmudov, Zhainagul Isakova, Nurbek Bakirov, Ernis Omurbaev, Alena Osipova, Ramaldan Ramaldanov, Elena Shagimardanova, Andrey Kiyasov, Oleg Gusev, Natalia Bodunova. The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz Republic. Current Issues in Molecular Biology 2023; 45(8) doi: 10.3390/cimb45080403
|
| 17 |
Shadin Ghabra, Andrew M. Blakely, Andrew Mannes, Ning Miao. Anesthesia for Oncological Surgery. 2023; doi: 10.1007/978-3-031-50977-3_42
|
| 18 |
Muxing Kang, Xiaojing Ma, Jifei Shi, Guofeng Chen, Xiaoli Jin, Jun Wang, Lele Lin, Zhiwei Wu, Kaibo Chen, Jinghong Xu, Pintong Huang, Jian Chen. Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach. Translational Oncology 2022; 19 doi: 10.1016/j.tranon.2022.101380
|
| 19 |
Jun Ishida, Yoshihide Nanno, Hirochika Toyama, Takuya Mizumoto, Dongha Lee, Takeshi Urade, Kenji Fukushima, Shohei Komatsu, Sadaki Asari, Hiroaki Yanagimoto, Masahiro Kido, Takumi Fukumoto. Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer. Annals of Surgical Oncology 2026; 33(2) doi: 10.1245/s10434-025-18491-3
|
| 20 |
Anant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, Anuj Gupta, Akhil Kapoor, Sujay Srinivas, Omshree Shetty, Poonam Jadhav, Veena Desai, Vanita Noronha, Amit Joshi, Nandini Menon, Vijay M Patil, Bal Krishna Mishra, Bipinesh Sansar, Arpita Singh, Swapnil Patel, Satyendra Narayan Singh, Ipsita Dhal, Kunal Ranjan Vinayak, Vikash Pal, Sarika Mandavkar, Sadhana Kannan, Deepali Chaugule, Rajshree Patil, Manali Parulekar, Chaitali Nashikkar, Suman Kumar Ankathi, Rajiv Kumar Kaushal, Aekta Shah, Prasanth Ganesan, Smita Kayal, Ramesh Ananthakrishnan, Noorzia Syed, Debdeep Samaddar, Venkatesh Kapu, Anokhi Shah, D Kaaviya, R Suganiya, Nirmala Devi Srinivasan, Kumar Prabhash, Vikas Ostwal. Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers. JNCI Cancer Spectrum 2024; 8(4) doi: 10.1093/jncics/pkae054
|